MedCity News August 28, 2024
Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space.
Historically, the medical devices world has been a highly proprietary industry, having long been characterized by the development of specialized, patented technologies that are closely guarded by their creators. You won’t find an App Store here with APIs handed out to developers to create tools off of a base technology.
In a surprising development, adversaries are becoming allies in at least one subset of the medtech world: diabetes.
This month,...
Today's Sponsors
Today's Sponsor